medicines shortages
Oral opioid shortages to continue
Shortages of Oxynorm capsules and Ordine oral liquid are expected to last until late 2024, the TGA reports Manufacturers of two oral opioid products are forecasting that shortages of some …
Diabetes shortages targeted in report
Shortages of existing diabetes medicines are likely to continue through 2024 and beyond, warns a new report which recommends strengthening the supply chain The 2024 State of the Nation report from Diabetes …
Antibiotics shortage warning
The NSW department of health has written to GPS warning them of a shortage in antibiotics “Azithromycin and clarithromycin oral liquids may be in short supply due to the current …
Vyvanse shortages return
Less than two months after the TGA declared shortages of Vyvanse to be “resolved” the regulator is now reporting the medication is once again in short supply The Therapeutic Goods …
Shortages a ‘major vulnerability’
Some specialists are only finding out about medicines shortages when alerted by pharmacists, patients or social media In its submission to the Therapeutic Goods Administration’s consultation on medicines shortages, the …
World news wrapup: 18 April 2024
Mexico exports illicit fentanyl but impacted by licit shortage; opposition to freeing of US pharmacist who diluted cancer drugs; Malta government acts behind closed doors on pharmacy, greens say Mexico …
Antibiotic shortage to continue
Bicillin L-A supply shortages set to continue, manufacturer warns Pfizer Australia has advised the Therapeutic Goods Administration (TGA) that stocks of its Bicillin L-A (benzathine benzylpenicillin tetrahydrate) prefilled syringes for injection (600,000 …
Ozempic isn’t approved for weight loss in Australia. So how are people accessing it?
Hundreds of thousands of people worldwide are taking drugs like Ozempic to lose weight. But what do we actually know about them? The Conversation’s experts, Andrew Bartlett, Jessica Pace and …
‘Like every service they must be used safely’
The TGA is looking at cracking down on the compounding of injectable weight loss medicines, following the concerns it expressed last year The Therapeutic Goods Administration has announced that it …
Opioid access: more action needed, say hospital pharmacists
Patients should not have to pay for unsubsidised morphine products brought in to manage the current shortage, says the SHPA Yesterday (28 February 2023), the AJP reported that the Therapeutic …
‘This is an emergency in our community’
Greens Senator asks about the status of ADHD medicine, and slams government over extended expected shortage At last week’s (15 February 2024) Senate Estimates hearings, Greens Senator Jordan Steele-John outlined …
Alphapharm extends fluoxetine shortage
Manufacturing issues are continuing to hinder the supply of Zactin Tabs (fluoxetine 20 mg dispersible tablets), TGA warns Alphapharm is forecasting that Zactin Tabs 20 mg dispersible tablets will continue to be …